Related by context. All words. (Click for frequent words.) 61 deletion 5q cytogenetic abnormality 61 myelodysplastic syndromes MDS 59 paroxysmal nocturnal hemoglobinuria PNH 58 unfavorable cytogenetics 58 deletion 5q 58 refractory acute promyelocytic 58 non splenectomized 58 purpura ITP 57 hyperphenylalaninemia HPA due 57 alpha1 antitrypsin AAT deficiency 57 Kepivance 57 aplastic anemia AA 56 chronic immune thrombocytopenic 56 chronic ITP 56 symptomatic BPH 56 neutropenia dehydration dyspnea 55 SJIA 55 immune thrombocytopenic purpura 55 relapsing remitting MS RRMS 55 cell chronic lymphocytic 55 exocrine pancreatic insufficiency EPI 55 myelodysplastic myeloproliferative diseases 55 neutropenia thrombocytopenia 55 myelodysplastic syndrome MDS 55 refractory chronic lymphocytic 55 severe renal impairment 55 lupus erythematosus 55 rheumatoid arthritis ankylosing spondylitis 55 Raptiva ® 55 Thalidomide Pharmion 54 post herpetic neuralgia PHN 54 decompensated liver disease 54 moderate renal impairment 54 Amgen Neulasta R 54 leukopenia 54 tumors GIST 54 pancreatic insufficiency 54 Atypical Hemolytic Uremic Syndrome 54 Raptiva R 54 chronic eosinophilic leukemia 54 severe renal insufficiency 54 leukemia APL 54 pediatric Crohn disease 54 thromboembolic complications 54 blood phenylalanine Phe 54 Cutaneous T 54 Chronic Hepatitis B 54 prasterone 54 aggressive systemic mastocytosis 54 PEGINTRON TM 54 opioid induced constipation OIC 54 non metastatic osteosarcoma 54 HES CEL 54 atherothrombotic events 53 BARACLUDE ® 53 RBC transfusion 53 ® lenalidomide 53 Mimpara 53 MDS MPD 53 valsartan amlodipine 53 chronic rheumatic 53 rheumatoid arthritis psoriatic arthritis 53 Ribavirin causes 53 RoACTEMRA 53 predominantly classic subfoveal 53 leukemia ALL 53 acute angioedema attacks 53 rheumatoid arthritis osteoarthritis ankylosing 53 renal insufficiency 53 Kit CD# positive 53 Wafer polifeprosan 53 R Saizen R 53 relapsed Acute Myeloid 53 Patients Treated With 53 ARIXTRA 53 Reminyl galantamine 53 idiopathic thrombocytopenic purpura ITP 53 chronic renal failure 53 chronic idiopathic thrombocytopenic purpura 53 onset diabetes mellitus 53 severe oral mucositis 53 REVLIMID lenalidomide 53 secondary hyperparathyroidism 53 anthracycline therapy 53 TORISEL 53 Losartan 53 A1PI 53 posterior uveitis 53 Myelodysplasia 53 Sebivo 52 immune idiopathic thrombocytopenic 52 Chronic Hepatitis C 52 refractory acute myeloid 52 Chronic Idiopathic Constipation 52 ocular hypertension 52 cinacalcet HCl 52 Certolizumab pegol 52 thrombocytopenia neutropenia 52 Relapsing Remitting Multiple Sclerosis 52 Gel repository corticotropin injection 52 idursulfase 52 Hong Kong incl Macau 52 TEMODAL 52 primary generalized tonic 52 hypereosinophilic syndrome 52 oropharyngeal candidiasis OPC 52 Neulasta R 52 metastatic malignant 52 orphan medicinal product 52 hepatorenal syndrome 52 adult chronic ITP 52 HBeAg positive patients 52 lymphocytosis 52 Amgen Neulasta ® 52 uterine fibroid induced 52 pheochromocytoma 52 Zorbtive TM 52 renal impairment 52 Myelodysplastic syndromes 52 RhD positive 52 refractory anaplastic astrocytoma 52 receiving INTRON 52 neurological manifestations 52 MULTAQ 52 diabetes mellitus T2DM 52 relapsed refractory multiple myeloma 52 grade cervical intraepithelial 52 Relapsed Refractory 52 chronic HBV infection 52 administered concomitantly 52 mycophenolic acid 52 primary immunodeficiency PI 52 Follicular Lymphoma 52 neurogenic bladder 52 acute myeloid 52 adrenocortical cancer 52 induced macular edema 52 arthritis PsA 52 EXJADE 52 anemia thrombocytopenia 52 autoantibody positive 52 pyrexia mucositis sepsis febrile 52 TheraCIM 52 stage IIIb IV 52 EGFR expressing mCRC 52 Peginterferon alfa 2b 52 recurrent glioblastoma multiforme 52 pancytopenia 52 unresectable 52 cytopenias 52 elevated ALT 52 sapropterin dihydrochloride 52 mildly symptomatic 52 1 proteinase inhibitor 52 non splenectomised 52 presumed ocular histoplasmosis 52 primary hypercholesterolemia 51 Certican 51 severe neutropenia 51 smoldering multiple myeloma 51 Congenital Emphysema 51 ASH Abstract # 51 induced anemia 51 Acute Myeloid Leukemia AML 51 COPAXONE ® 51 COPAXONE R 51 6 phosphate dehydrogenase 51 Zavesca R 51 Fludara ® 51 unresectable recurrent 51 mRCC 51 alanine aminotransferase 51 tuberous sclerosis TS 51 metastatic GIST 51 moderate hepatic impairment 51 included neutropenia anemia 51 induce orthostatic hypotension 51 bone marrow reticulin deposition 51 BUPHENYL 51 PEGylated anti 51 NYHA Class II 51 unstable angina pectoris 51 moderate immunologic 51 partial onset seizures 51 REVLIMID ® 51 Myelodysplastic Syndromes MDS 51 subependymal giant cell 51 HYVISC R 51 metastatic colorectal carcinoma 51 beta thalassemia 51 grade cervical dysplasia 51 Navelbine ® 51 hemodynamically significant 51 thalassemia sickle cell 51 pancreatic alpha 51 homozygous familial hypercholesterolemia 51 chronic granulomatous disease 51 receiving Vectibix monotherapy 51 humanized interleukin 6 51 Adjuvant Treatment 51 vWD 51 terlipressin 51 hereditary deficiency 51 Ph + acute lymphoblastic 51 XAGRID 51 β blocker 51 situ CIS 51 reduce serum phosphate 51 Tasigna nilotinib 51 Granulocyte Colony Stimulating Factor 51 severe idiopathic Restless 51 Neovascular 51 HNSCC 51 AAT deficiency 51 generalized edema 51 carmustine implant 51 novel VDA molecule 51 acute HAE attacks 51 Paroxysmal Nocturnal Hemoglobinuria 51 anagrelide 51 tumor lysis syndrome 51 R abatacept 51 non valvular atrial 51 pharyngitis tonsillitis 51 leucopenia 51 transplantation HCT 51 discontinued Viread 51 Lupus nephritis 51 NEUPOGEN R 51 advanced hepatocellular carcinoma 51 cutaneous T 51 haematologic 51 stable angina pectoris 51 splenectomized 51 romiplostim 51 hoFH 51 ORENCIA ® 51 RANK Ligand inhibitor 51 Uricase PEG 51 metastatic dermatofibrosarcoma protuberans DFSP 51 enzyme elevations 51 Chronic ITP 51 candesartan cilexetil 51 proliferative diabetic retinopathy 51 patients receiving myelosuppressive 51 Platelet Counts 51 RhD negative 51 nephrotoxicity 51 leukemia CLL 51 Angiox R 51 CTAP# Capsules 51 intravesical therapy 51 sapropterin dihydrochloride Tablets 51 hypercholesterolaemia 51 Amrubicin 51 recurrent colorectal cancer 51 CIMZIA TM certolizumab pegol 51 juvenile myoclonic epilepsy 51 acute myelogenous leukemia AML 51 Chronic lymphocytic leukemia CLL 51 hepatitis B HBV 51 systemic juvenile idiopathic 51 HBeAg negative 51 grade squamous intraepithelial 51 FOLOTYN ® 51 dose corticosteroids 51 SPRYCEL ® 50 MEZAVANT R 50 Infusion Reactions Severe 50 thrombocytopenic 50 chronic HBV 50 cutaneous manifestations 50 herpetic keratitis 50 heFH 50 myeloproliferative neoplasms 50 STELARA TM 50 leukemia AML 50 headache abdominal pain 50 diarrhea predominant irritable 50 chronic thromboembolic pulmonary 50 hypercalcemia 50 neutrophil counts 50 Solzira TM 50 oral antidiabetic medication 50 metastatic gastric 50 Buerger Disease 50 deep venous thromboses 50 undergoing coronary angioplasty 50 mcg kg REBETOL 50 platelet count 50 sitaxsentan sodium 50 refractory cutaneous T 50 azacitidine 50 QVAR R 50 Gliadel R 50 concomitant myelosuppressive chemotherapy 50 EPOGEN R 50 Chronic Myelogenous Leukemia CML 50 corticotropin injection 50 FluCAM arm 50 hematologic toxicity 50 potent CYP#A# inhibitors 50 poor metabolizers 50 mild renal insufficiency 50 severe hypercholesterolemia 50 SORT OUT III 50 palifermin 50 Dermatologic toxicities 50 Flu Cy 50 retinal vein occlusion RVO 50 CrCl 50 pioglitazone HCl 50 Letairis ambrisentan 50 Plicera TM 50 Injectable Solution 50 haematopoietic stem cell 50 B CLL 50 interferon beta 1a infertility 50 HeFH 50 severe malignant osteopetrosis 50 BCG refractory carcinoma 50 cerebrovascular disorders 50 Lithuania Luxembourg 50 Orphan Drug status 50 Gamunex C 50 draining enterocutaneous 50 methylnaltrexone bromide 50 R fenofibrate capsules 50 beclomethasone dipropionate 50 LymphoStat B belimumab 50 Neovascular Age Related Macular 50 neovascular age 50 diarrhea vomiting rash 50 Pivotal Phase III 50 Romiplostim 50 efalizumab 50 Mg Uk 50 cell lymphoma CTCL 50 moderate renal insufficiency 50 HBeAg + 50 Sirolimus eluting Coronary Stent 50 Helicobacter pylori eradication 50 genotype 1b 50 dirucotide MBP# 50 TNF Tumor Necrosis Factor 50 R lenalidomide 50 C1 esterase inhibitor 50 phenylketonuria PKU 50 ketoconazole USP Gel 50 T2DM 50 common hematologic malignancy 50 biologic DMARD 50 commercialize taliglucerase alfa 50 non hematological toxicities 50 hepatocellular carcinomas 50 dose escalation clinical 50 Azacitidine 50 unresectable hepatocellular carcinoma HCC 50 histologic subtype 50 hyperlipidaemia 50 rheumatoid arthritis RA psoriatic 50 R bendamustine hydrochloride 50 Eltrombopag 50 Chronic Heart Failure 50 colorectal carcinoma 50 posaconazole 50 peginterferon alfa 2a Pegasys 50 ara C 50 juvenile idiopathic arthritis JIA 50 patients coinfected 50 Lambert Eaton Myasthenic 50 TELINTRA 50 ATryn ® GTC recombinant 50 Metered Dose Inhaler Devices 50 elevated triglyceride levels 50 receiving XGEVA 50 Mimpara R 50 papillary renal cell carcinoma 50 follicular lymphoma FL 50 clonic seizures 50 hypercholesterolemia 50 macroalbuminuria 50 ARCOXIA 50 SGPT 50 PEG INTRON R 50 Myelodysplastic Syndrome MDS 50 atrophic gastritis 50 Granted Orphan Drug 50 insomnia characterized 50 Severe Primary IGFD 50 methylnaltrexone bromide subcutaneous injection 50 intraventricular hemorrhage 50 HBeAg negative patients 50 Fast Track designations 50 psoriatic arthritis PsA 50 hypophosphatemia 50 formerly LymphoStat B 50 Smecta R 50 unstable angina UA 50 elevated serum creatinine 50 Zavesca r 50 del 5q MDS 50 dysmotility 50 neurogenic orthostatic hypotension 50 porcine derived 50 Acute Myelogenous Leukemia AML 50 recurrent UTI 50 interferon alfa 2b 50 alefacept 50 homozygous FH 50 metabolic alkalosis 49 ribavirin therapy 49 g dl 49 Forodesine HCl 49 Ranolazine 49 Receives Orphan Drug Designation 49 hereditary angioedema HAE 49 metastatic renal cell carcinoma 49 cinacalcet 49 hypomagnesemia 49 Sensipar R 49 pruritus rash 49 hemoglobin concentration 49 AST ALT 49 primary humoral immunodeficiency 49 hypercholesterolemic patients 49 Acute Bacterial Sinusitis ABS 49 congenital ichthyosis 49 Receives Positive Opinion 49 psoralen plus ultraviolet 49 NEUPOGEN 49 severe Primary IGFD 49 Serostim ® 49 aminotransferase ALT 49 Natalizumab 49 von Willebrand disease 49 QVAR ® 49 Chronic lymphocytic leukemia 49 MPS VI 49 Tiuxetan 49 GH deficiency 49 polycythemia vera essential thrombocythemia 49 Newly Diagnosed Chronic Myeloid 49 Acute Myeloid Leukaemia 49 cardiometabolic diseases Glucophage 49 pulmonary arterial hypertension 49 Kristalose ® lactulose 49 receiving prophylactic anticoagulation 49 GTC recombinant human 49 severe hepatic insufficiency 49 immune thrombocytopenic purpura ITP 49 calcineurin inhibitor 49 Orphan Medicinal Product 49 Systemic Lupus Erythematosus 49 peripheral neuropathy aggravated 49 Hypokalemia 49 diarrhea CDAD 49 infliximab monotherapy 49 dyslipidaemia 49 Telintra 49 Prulifloxacin 49 SomatoKine R 49 REYATAZ r arm 49 Gonal f R follitropin 49 receiving immunosuppressive therapy 49 demethylation agents 49 RBC transfusions 49 latent tuberculosis infection 49 Syndrome LEMS 49 mitoxantrone plus 49 everolimus tablets 49 subclinical hypothyroidism 49 #mg QD [002] 49 Chronic Lymphocytic Leukemia 49 Nilotinib 49 non resectable metastatic 49 DOXIL R 49 TRISENOX R arsenic trioxide 49 metastatic neuroendocrine tumors 49 tirofiban 49 Newly Diagnosed Multiple Myeloma 49 aHUS 49 gastric carcinoma 49 elevated intraocular pressure 49 PSA nadir 49 anemia hemoglobin 49 rasagiline tablets 49 febrile neutropenia 49 cIAI 49 autoimmune disorder characterized 49 relapsed acute myelogenous 49 patients undergoing percutaneous 49 PNH patients 49 Brilique 49 Receives Marketing Authorization 49 relapsed acute lymphoblastic 49 carcinoma HCC 49 Polyneuropathy 49 Ovitrelle R Serostim 49 Revolade 49 dexamethasone Decadron 49 hydroxymethyl coenzyme 49 hepatic impairment 49 epoetin beta 49 amebiasis 49 oral aromatase inhibitor 49 infusional 5-FU/LV 49 PROMACTA 49 mecasermin 49 ergot derivatives 49 venous thromboembolic events 49 heterozygous FH 49 glatiramer acetate injection 49 PRN FDA Approves 49 Dementia Related Psychosis 49 REPLAGAL 49 INVANZ 49 mg kg Hematide 49 follicular CD# positive 49 hypertrichosis occurred 49 metabolic disorders Saizen R 49 achieved sustained virological 49 fluvastatin 49 oxymorphone ER 49 exocrine pancreatic insufficiency 49 Ondansetron Injection USP 49 candidemia 49 active ankylosing spondylitis 49 steroid refractory ulcerative 49 Refractory Peripheral T 49 glucocorticoid therapy 49 known teratogen substance 49 Latvia Lithuania Luxembourg 49 Clevudine 49 baseline HbA1c 49 CMV seropositive 49 Cinryze ™ 49 ankylosing spondylitis AS 49 familial hypercholesterolemia 49 MEZAVANT 49 treats paroxysmal nocturnal 49 colesevelam HCl 49 arsenic trioxide injection 49 anemia neutropenia 49 PROVIGIL ® 49 ATACAND 49 memantine HCl 49 Hypogonadism 49 Interferon beta 1b 49 diabetic nephropathy 49 Mycophenolate Mofetil 49 System IPSS 49 occlusive disease 49 Squamous 49 Severe Sepsis 49 alpha1 antitrypsin deficiency 49 Syndrome HARS 49 dasatinib Sprycel ® 49 interstitial pneumonitis 49 Noxafil 49 IV NSCLC 49 unresectable liver cancer 49 mIU L 49 adjunctive ABILIFY 49 piperacillin tazobactam 49 Orphan Drug designations 49 Asian-American/Pacific Islanders 49 VPRIV 49 hereditary antithrombin deficiency 49 vapreotide acetate 49 Chronic Myeloid Leukemia 49 paroxysmal nocturnal hemoglobinuria 49 hypokalemia hypomagnesemia 49 chronic plaque psoriasis 49 Evoltra ® 49 stage IIIB 49 mEq L 49 achieved ACR# 49 patients undergoing CABG 49 ALT flares 49 CIMZIA R 49 NPH insulin 49 methotrexate therapy 49 ORENCIA R 49 transaminase levels 49 somatropin rDNA origin 49 intravenous AAT 49 thrombocytosis 49 RELISTOR methylnaltrexone bromide 49 Keppra ® 49 Alphanate R 49 FACTIVE ® 49 unresectable locally advanced 49 HoFH 49 Tibotec Therapeutics division 49 BENICAR HCT 49 develop HBV reactivation 49 proliferator activated receptor 49 epinastine nasal spray 49 CIMZIA r 49 NOXAFIL 49 rizatriptan 49 Zavesca ® 49 Coadministration 49 unknown etiology 49 orphan designation 49 pediatric acute lymphoblastic 49 trimethoprim sulfamethoxazole 49 Pemetrexed 49 neutrophil count 49 localized renal 49 Sanvar R 49 basiliximab 49 urinary albumin excretion 49 interferon gamma 1b 49 Metastatic Colorectal Cancer 49 failure NYHA 49 TNF antagonist 49 hematologic disorders 49 lipohypertrophy 49 serum aminotransferase levels 49 Preotact R 49 pegfilgrastim 49 myeloproliferative diseases 49 failure ADHF 49 Soft Tissue Sarcoma 49 del 5q 49 hypoparathyroidism 49 controlled dose escalation 49 lomitapide 49 basal bolus therapy 49 Elitek 49 factor G CSF 49 Myfortic 49 Relapsed 49 oral FTY# 49 ZOSTAVAX 49 grade gliomas 49 intrinsic sphincter deficiency 49 thromboembolic events 49 nausea dehydration dyspnea 49 severe hypersensitivity reactions 49 infantile spasms IS 49 Romania #.# +#.# 49 Oral lyn ™ 48 IG IGS ;) COUNTRY 48 rFVIIa 48 SYCREST 48 neutropenic patients 48 HIV HCV coinfected 48 AVASTIN 48 recurrent NSCLC 48 anginal symptoms 48 severely active polyarticular 48 Lispro 48 overactive bladder syndrome 48 mCRC patients 48 placebo dexamethasone 48 tazobactam 48 thrombocytopenic patients 48 approved incretin mimetic 48 Castration Resistant Prostate Cancer 48 Cimzia ® 48 familial amyloidotic polyneuropathy FAP 48 developing Bicifadine serotonin 48 REBETOL combination 48 nitrofurantoin 48 Nonspecific 48 International Prognostic Scoring 48 evaluating REVLIMID 48 DOXIL 48 antiplatelet agent 48 invasive candidiasis 48 pulmonary artery hypertension 48 recurrent ovarian cancer 48 Vitrasert R 48 Chronic Constipation 48 recombinant interferon 48 untreated AML 48 Torisel 48 hematological cancers notably 48 Thal Dex 48 PLX STROKE targeting 48 Patients Treated 48 C1 Inhibitor 48 HBeAg positive 48 INVEGA ® 48 PENTASA 48 IV FENTORA R 48 somatropin Kuvan R 48 nondiabetic patients 48 DPNP 48 Primary IGFD 48 chronic ITP patients 48 salmeterol HFA MDI 48 lactic acidosis 48 PegIntron 48 complement inhibitor eculizumab 48 Asymptomatic 48 lintuzumab SGN 48 Successfully Treats 48 APTIVUS ritonavir 48 percutaneous transluminal coronary angioplasty 48 CC genotype 48 Acute renal failure 48 Nimotuzumab 48 severe bronchial asthma 48 de novo AML 48 Pegasys peginterferon alfa 2a 48 abacavir lamivudine 48 dermatologic toxicities 48 refractory gout 48 VIIBRYD 48 BUPHENYL R sodium phenylbutyrate 48 mycophenolate mofetil MMF 48 artery stenosis 48 Allergic Rhinitis 48 Nplate 48 Gonal f 48 acute GvHD 48 Serostim R 48 Aviptadil 48 severe NCI CTC 48 Increlex TM 48 AGHD 48 Kuvan R 48 euthyroid 48 Increlex R 48 painful diabetic neuropathy 48 unresectable HCC 48 G CSFs 48 Neutropenia 48 renal disease 48 Stargardt Macular Dystrophy SMD 48 included exfoliative dermatitis 48 Marketing Authorisation Application 48 Heterozygous Familial Hypercholesterolemia 48 metastatic carcinoma 48 Sweden Everlasting Moments 48 acetonide FA 48 1mg tablets 48 lupus nephritis 48 taxane resistant 48 CIMZIA ™ 48 chronic hepatitis cirrhosis 48 hemoglobin Hb 48 Systemic Lupus Erythematosus SLE 48 systemic corticosteroid 48 Orphan Status 48 onset idiopathic hypogonadism 48 worsening thrombocytopenia 48 Positive Opinion 48 hsCRP levels 48 CKD Stage 48 Meets Primary Endpoint 48 Advanced Renal Cell 48 peripheral neuropathic pain 48 Pegloticase 48 plus COPEGUS 48 Gaucher Disease 48 chronic idiopathic 48 testosterone buccal system 48 atypical Hemolytic Uremic Syndrome 48 capillary leak 48 chronic angina 48 transaminase elevations 48 primary aldosteronism 48 Dacogen decitabine 48 systemic lupus erythematosus psoriasis 48 serum prostate 48 SGOT 48 Venezuela severs ties 48 GTC recombinant form 48 sorafenib tablets 48 thiazolidinedione 48 IXEMPRA 48 pleural effusion 48 adjunctive placebo 48 Eur J Endocrinol 48 renal artery stenosis 48 transfusional iron overload 48 Diffuse Large B 48 Oral lyn tm 48 pegylated interferon alpha 48 Azilect R 48 hemoglobin concentrations 48 IIIa inhibitor 48 Hp2 2 48 relapsed multiple myeloma 48 phase IIb trial 48 pamidronate 48 R darbepoetin alfa 48 dornase alfa 48 pathologic myopia 48 BENLYSTA belimumab 48 Brentuximab Vedotin SGN 48 Peginterferon 48 IBS C 48 hyperprolactinemia 48 diabetes mellitus 48 haematological 48 oral hypoglycemic agent 48 naïve HCV 48 Octreolin 48 PEG IFN 48 glycated hemoglobin levels 48 pegIFN 48 alpha interferons 48 hypocalcemia 48 PEGylated interferon beta 1a 48 CLL SLL 48 grade glioma 48 Hypomagnesemia occurred 48 graft dysfunction 48 myocardial infarction ventricular fibrillation 48 β blockers 48 known sulfonamide allergy 48 Vidaza azacitidine 48 valdecoxib 48 Berinert 48 neutropenic fever 48 primary dysmenorrhea 48 Cryopyrin Associated Periodic Syndromes 48 thrombophlebitis 48 serum creatinine levels 48 Rasilez HCT 48 recurrent genital herpes 48 Sevelamer 48 Complicated Skin 48 Secondary Hyperparathyroidism 48 sertraline Zoloft 48 leukemia CML 48 ACTIQ ® 48 Naive Patients 48 mifamurtide 48 thyrotoxicosis 48 ZYVOX 48 parathyroid carcinoma 48 dihydrochloride 48 gastrointestinal stromal tumors 48 Oral Fingolimod 48 coagulation disorders 48 Previously Treated 48 intracranial hemorrhage ICH 48 Seroquel quetiapine fumarate 48 IG ENE ;) COUNTRY 48 gastrointestinal mucositis 48 Lactic acidosis 48 hypercalcaemia 48 chronic hepatitis B. 48 receiving VELCADE 48 acute peptic ulcer 48 5q deletion 48 peripheral sensory neuropathy 48 prehypertensive 48 hematological parameters 48 N Engl J 48 sodium glucose cotransporter 48 metformin accumulation 48 hypervascular tumors 48 SNT-MC#/idebenone 48 Completes Patient Enrollment 48 enterocolitis 48 adverse cytogenetics 48 Myelodysplastic Syndromes 48 SEBIVO 48 STRIANT R 48 pancreatic NET 48 TREDAPTIVE 48 lymphopenia 48 EGFR mutation positive 48 myopathy rhabdomyolysis 48 endocrine abnormalities 48 baseline serum creatinine 48 weekly subcutaneous injections 48 treatment naïve genotype 48 acne pustular acne 48 underwent resection 48 non constipation irritable 48 TG MV 48 hepatic dysfunction 48 Progressive Multifocal Leukoencephalopathy 48 unresectable tumors 48 peritumoral brain edema 48 coinfection 48 Short Bowel Syndrome 48 prophylactic therapy 48 CE marked PROGENSA 48 injectable emulsion 48 allogeneic bone marrow 48 dalteparin 48 monocytic 48 Arch Intern Med 48 Recombinant interferon alpha 48 secondary hyperparathyroidism SHPT 48 Cimzia certolizumab pegol 48 C1 INH deficiency 48 STELARA 48 COPD exacerbation 48 PTLD 48 additional cytogenetic abnormalities 48 angioedema attacks 48 ß blockers 48 Inhalation Aerosol 48 x ULN 48 antidiabetic drug 48 Pulmonary arterial hypertension 48 Rh positive 48 breast carcinoma 48 NovoRapid 48 leiomyomas 48 blood clotting disorder 48 Oncophage vitespen 48 ertapenem 48 danazol 48 G6PD deficiency 48 APGROUP NorthAmerica ;) COUNTRY 48 EGFR expressing metastatic colorectal 48 concomitant AEDs 48 R imatinib mesylate 48 five MDS subtypes 48 Previously Untreated 48 K ras mutations 48 chronic opioid 48 Pharmacokinetics PK 48 stenoses 48 Prepaid Blended Postpaid Prepaid 48 cell lymphoma PTCL 48 hereditary pancreatitis 48 acute myocardial infarction AMI 48 treating myopia 48 benzoic acid hyoscyamine sulfate 48 opioid induced constipation 48 Zevalin R Ibritumomab 48 Commence Phase 48 FROVA 48 R metformin Concor 48 fluorouracil leucovorin 48 oral iron chelator 48 modafinil Tablets C 48 immune globulin intravenous 48 immunomodulatory therapy 48 parecoxib 48 highest tertile 48 oropharyngeal candidiasis 48 rheumatoid arthritis Crohn disease 48 bioavailable testosterone 48 primary Restless Legs 48 Serious adverse reactions 48 Filgrastim 48 Bottled Water Market 48 relapsed ovarian cancer 48 tacrolimus capsules 48 Myocardial Infarction Study 48 intrahepatic bile duct 48 NAGS deficiency 48 Leukemia AML 48 situ LCIS 48 cerebrovascular accident 48 insulin secretagogue 48 diabetic peripheral neuropathic pain 48 RBC folate 48 FASLODEX 48 dilated cardiomyopathy DCM 48 TRISENOX R 48 disseminated intravascular coagulation DIC 48 BENLYSTA ® 48 pulmonary infiltrates 48 GnRH agonist 48 C1 inhibitor deficiency 48 ARIXTRA R 48 uremic pruritus 48 pmol liter 48 Ejection Fraction 48 corticosteroids immunoglobulins 48 Ophthalmic Solution 48 Relapsing Multiple Sclerosis 48 Known hypersensitivity 48 colorectal liver 48 J Am Coll 48 Yondelis ® 48 FIRMAGON 48 aspirin clopidogrel 48 SHPT 48 Sezary syndrome 47 5-fluorouracil/leucovorin 47 PGL# 47 Hypotension 47 gastrointestinal GI motility disorders 47 cell lymphoma ALCL 47 Raymond Soeoth 47 Rasilez ® 47 sunitinib Sutent 47 smoldering myeloma 47 refractory NSCLC 47 AAT Deficiency 47 stage IIIA 47 brand ciclesonide HFA 47 Alair Bronchial Thermoplasty System